Roberto de Franchis, Aleksander Krag Journal of Hepatology

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 63, Issue 1, Pages (July 2015)

Volume 65, Issue 3, Pages (September 2016)

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Volume 46, Issue 3, Pages (March 2007)

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Inflammasomes in liver diseases

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Thrombocytopenia With Abnormal Liver Function Tests

Primary prevention of variceal haemorrhage: A pharmacological approach

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Volume 61, Issue 6, Pages (December 2014)

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Reactive oxygen species in the normal and acutely injured liver

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

Rachel H. Westbrook, Andrew D. Yeoman, John G. O'Grady, Phil M

Non-invasive diagnosis of non-alcoholic fatty liver disease

Immigration and viral hepatitis

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Volume 66, Issue 1, Pages 1-4 (January 2017)

Living donor liver transplantation: is the hype over?

European Association for the Study of the Liver Journal of Hepatology

Volume 42, Issue 4, Pages (April 2005)

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Stephen A. Harrison, MD, FACP Clinical Gastroenterology and Hepatology

Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure” Rakhi Maiwall,

Autoimmune hepatitis: A life-long disease

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

European Association for the Study of the Liver Journal of Hepatology

Hepatitis C core protein – The “core” of immune deception?

Vincent Leroy, Jean-Pierre Zarski Journal of Hepatology

Amalia Gastaldelli, Giulio Marchesini Journal of Hepatology

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Aloysious D. Aravinthan, Graeme J.M. Alexander Journal of Hepatology

Volume 54, Issue 5, Pages (May 2011)

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Genomic risk of hepatitis C-related hepatocellular carcinoma

EASL Clinical Practice Guidelines: Wilson’s disease

Use of hemospray for non-variceal esophageal bleeding in an infant

Volume 41, Issue 4, Pages (October 2004)

The changing role of beta-blocker therapy in patients with cirrhosis

Volume 57, Issue 5, Pages (November 2012)

AGA technical review on nonalcoholic fatty liver disease

Non-invasive diagnosis and biomarkers in alcohol-related liver disease

Paul C. Adams, James C. Barton Journal of Hepatology

Portal vein thrombosis, cirrhosis, and liver transplantation

Immigration and viral hepatitis

Global burden of alcoholic liver diseases

HCV targeting of patients with cirrhosis

Volume 64, Issue 6, Pages (June 2016)

Esophageal variceal bleeding: Primary prophylaxis

Volume 63, Issue 1, Pages (July 2015)

Familial amyloidosis: Great progress for an orphan disease

Volume 66, Issue 1, Pages (January 2017)

Thrombocytopenia With Abnormal Liver Function Tests

Shunt dysfunction: Is it suitable as the primary end point in transjugular intrahepatic portosystemic shunt trials? Jingzhi Cai, Wengang Guo, Chuangye.

Liver transplantation in children

Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi

Reply to: “Flow cytometry makes all the difference”

Pathogenesis of cholestatic hepatitis C

Chimeric mouse model of hepatitis B virus infection

Volume 44, Issue 1, Pages (January 2006)

Results of six hundred thirty-six esophageal transections with paraesophagogastric devascularization in the treatment of esophageal varices Mitsuo Sugiura,

Volume 50, Issue 1, Pages 4-6 (January 2009)

Thierry Gustot, Rajiv Jalan Journal of Hepatology

Outcomes in liver transplantation: Does sex matter?

Presentation transcript:

Ruling out esophageal varices in NAFLD cirrhosis: Can we do without endoscopy? Roberto de Franchis, Aleksander Krag Journal of Hepatology Volume 69, Issue 4, Pages 769-771 (October 2018) DOI: 10.1016/j.jhep.2018.06.013 Copyright © 2018 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Screening algorithm for patients with non-alcoholic fatty liver disease. LSM, liver stiffness measurement; NAFLD, non-alcoholic fatty liver disease; PLT, platelet count. Journal of Hepatology 2018 69, 769-771DOI: (10.1016/j.jhep.2018.06.013) Copyright © 2018 European Association for the Study of the Liver Terms and Conditions